Prediction of radiation pneumonitis following high-dose thoracic radiation therapy by 3 Gy/fraction for non-small cell lung cancer: analysis of clinical and dosimetric factors

Jpn J Clin Oncol. 2009 Mar;39(3):151-7. doi: 10.1093/jjco/hyn158. Epub 2009 Feb 3.

Abstract

Objective: This study was undertaken to identify the factors predictive of radiation pneumonitis (RP) in 69 non-small cell lung cancer patients treated with thoracic radiation therapy only by 3 Gy fractions.

Methods: A total of 69 patients who received only RT in daily 3 Gy were included in this study. Grade > or =3 RP was defined as an RP event. The cumulative incidence of RP was estimated and the correlations of the development of RP with the potential predictors were determined.

Results: The cumulative incidence of events was 17.1% at 12 months. By univariate analysis, all clinical factors [age, performance status, weight loss, pre-RT forced expiratory volume in 1 s, tumour location, stage, RT dose and clinical target volume] were not associated with the risk of Grade > or =3 RP; however, all dosimetric factors [V5-50 and mean lung dose (MLD)] closely correlated with the development of RP. The receiver-operative characteristics (ROC) analysis revealed that MLD was the best predictors of Grade > or =3 RP (area under curve ROC = 0.937). By multivariate analysis, MLD was the only significant factor to be predictive of RP risk: the probability of Grade > or =3 RP was 3.7% when MLD < or = 16.1 Gy and 78.4% when MLD > 16.1 Gy.

Conclusions: Dosimetric parameters were valuable in predicting the development of RP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Analysis of Variance
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Carcinoma, Non-Small-Cell Lung / radiotherapy*
  • Dose Fractionation, Radiation
  • Dose-Response Relationship, Radiation
  • Female
  • Humans
  • Incidence
  • Lung Neoplasms / pathology
  • Lung Neoplasms / radiotherapy*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm Staging
  • Pneumonia / etiology*
  • Predictive Value of Tests
  • Prognosis
  • ROC Curve
  • Radiotherapy / adverse effects
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors